Structure Therapeutics Inc. (NASDAQ:GPCR) is a clinical-stage biopharmaceutical company developing oral small-molecule therapies for metabolic diseases such as obesity and diabetes.

"At quite advanced stages now." Researchers develop game-changing solution for major issue in food supply: 'We now have the ...

The sugar, HSAT, is a potential target for slowing metastasis in pancreatic ductal adenocarcinoma, the most common pancreatic cancer.

The Genentech investment is a line of several major investments in Southern Wake County, and is expected to generate roughly 1,500 construction jobs and more than 400 manufacturing jobs once the ...

Roche is set to acquire 89bio for up to $3.5 billion, gaining access to the promising liver disease drug pegozafermin. This ...

Miami’s startup scene is really taking off, especially in the biotech world. It feels like every other week there’s a new ...

As investors continue to pour money into AI startups in the U.S., Seattle ranks fourth in the nation in AI funding, ...

A deal with Dutch startup VarmX gives CSL an option to buy a Phase 3-ready drug that could reverse the effects of popular ...

Since the material prolongs the shelf life of fruits and vegetables, customers can save money on groceries while enjoying ...

Shareholders continued to sell down CSL despite its investment in a blood disorder biotech, saying they want more signs of ...

The world of biotech is really changing fast. It feels like every year there’s some new big thing happening. As we look towards 2025, it seems like a lot of exciting developments are on the horizon.

KOCHI: In a significant push for the state’s ambition to attract major investment projects, Bengaluru-based RCC Nutrafill ...